Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
03/2015
03/05/2015WO2015031725A1 Transition metal-catalyzed imidation of arenes
03/05/2015WO2015031295A1 Ido inhibitors
03/05/2015WO2015030002A1 Method for producing optically active 5-hydroxy-3-ketoester compound
03/05/2015WO2015030001A1 Method for manufacturing optically active 5-hydroxy-3-ketoesters
03/05/2015WO2015027773A1 Application of dmap hydrochloride serving as recyclable catalyst in acylation reaction
03/05/2015US20150065716 Compound, optical resolution method, and derivative of an optical isomer of an amino acid
03/05/2015US20150065538 Trpa1 antagonists
03/05/2015US20150065489 Substituted Quinolines and Their Use As Medicaments
03/05/2015US20150065487 Modulators of atp-binding cassette transporters
03/05/2015US20150065471 Salts of 5-[(1r)-2-(amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one
03/05/2015US20150064168 Cadherin-11 Inhibitors and Methods of Use Thereof
03/03/2015US8969577 Curable composition comprising a thermolatent base
03/03/2015US8969569 Salt and crystalline forms thereof of a drug
03/03/2015US8969552 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
03/03/2015US8969381 Chemokine CXCR4 receptor modulators and used related thereto
03/03/2015US8969380 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
03/03/2015US8969379 Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide
03/03/2015US8969378 Inhibitor of the differentiation of T cells into Th1 cells
03/03/2015US8969377 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
03/03/2015US8969341 Pyrazolopyrrolidine compounds
03/03/2015US8969333 Therapeutic compositions and methods
03/03/2015US8969325 TRPV1 antagonists
02/2015
02/26/2015WO2015024448A1 Benzo piperidine ring and benzo morpholine ring compounds, manufacturing method therefor, and medical applications thereof
02/26/2015US20150057312 Substituted quinolines as bruton's tyrosine kinases inhibitors
02/26/2015US20150057311 Heterocyclic GSK-3 Allosteric Modulators
02/26/2015US20150057310 Malate salt of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
02/26/2015US20150057279 Heteroaryl compounds with a-cyclic bridging unit
02/26/2015US20150057256 Novel polymorphic crystal forms of 5-(2--1-(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisytlate as agonist of the beta2 adrenergic receptor
02/25/2015EP2840081A1 Use of a novel aminopyridine derivative to prevent or treat cancer
02/25/2015EP2840076A1 Bicyclic compound
02/25/2015EP2838882A1 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
02/24/2015US8963813 Organic compound and organic light emitting device having the same
02/24/2015US8962655 Composition for treatment of undifferentiated gastric cancer
02/24/2015US8962650 Therapeutic agent for tumor
02/24/2015US8962598 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as AHR activators
02/24/2015US8962244 Compounds for modulating RNA binding proteins and uses therefor
02/24/2015CA2771403C Quinoline derivative-containing pharmaceutical composition
02/24/2015CA2631491C Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
02/19/2015WO2015022265A2 Novel compounds
02/19/2015US20150051245 Kinase protein binding inhibitors
02/19/2015US20150051233 Methods and compositions for treatment of fibrosis
02/19/2015US20150051205 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
02/19/2015US20150051177 Methods and compositions useful in treating cancer and reducing wnt mediated effects in a cell
02/18/2015EP2836483A1 Anti-malarial agents
02/17/2015US8957092 Quinoline derivatives and their use as tyrosine kinase inhibitors
02/17/2015US8957090 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
02/17/2015US8957087 Heterocyclic substituted acardite derivate and application thereof
02/17/2015US8957084 7,8-cyclicmorphinan analogs
02/17/2015US8957075 O-GlcNAc transferase inhibitors and uses thereof
02/17/2015US8956656 Production of small particles
02/17/2015CA2670763C 4-(1-amino-ethyl)-cyclohexylamine derivatives
02/12/2015US20150047073 Synthetic compounds for vegetative aba responses
02/12/2015US20150045374 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
02/12/2015US20150045354 Anti-Malarial Agents
02/11/2015EP2834219A1 Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one
02/11/2015CN104341345A 一种2-甲氧基-6-酮-5,6,7,8-四氢喹啉的合成方法 One kind of 2-methoxy-5,6,7,8-tetrahydro-quinolin-6-one The synthetic method
02/11/2015CN104341344A 一种3-(2-甲基喹啉-6-基)丙酰胺的制备方法 Preparation of 3-(2-methyl-quinolin-6-yl) propionamide
02/11/2015CN102786375B 一种9-烷基烯基-2,7-二芳基芴衍生物及其应用 One kind 9- alkyl alkenyl-2,7-diaryl fluorene derivatives and their Applications
02/10/2015US8952207 Copper-catalyzed C—H bond arylation
02/10/2015US8952163 Substituted hydroxamic acids and uses thereof
02/10/2015US8952161 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
02/10/2015US8952035 Combination of anti-angiogenic substance and anti-tumor platinum complex
02/10/2015US8952009 Chroman derivatives as TRPM8 inhibitors
02/10/2015US8952007 Fused heterocyclic compounds as ion channel modulators
02/10/2015US8951999 Compounds
02/05/2015WO2015014230A1 Matrix metalloproteinase inhibitor and use thereof
02/05/2015US20150038531 Use of a novel aminopyridine derivative to prevent or treat cancer
02/05/2015US20150038493 Compounds that trap alpha-oxoaldehydes and alpha-beta-unsaturated aldehydes, meta-compounds containing such compounds, and use of said compounds in treating illnesses related to the accumulation of ages and ales
02/05/2015US20150037397 Pharmaceutical compositions of pyridinium and quinolinium derivatives
02/04/2015EP2831047A1 Pfkfb3 inhibitor and methods of use as an anti-cancer therapeutic
02/04/2015EP2831042A1 Heteroaryl compounds with a-cyclic bridging unit
02/04/2015EP2830615A1 Heteroaryl compounds with cyclic bridging unit for use in the treatment helminth infection
02/04/2015CN104334527A 磺酰胺化合物及作为tnap抑制剂的用途 Sulfonamide compound and as tnap INHIBITORS
02/04/2015CN104327065A 一种n-甲基-(喹啉-4-基)甲烷胺的制备方法 One kind n- methyl - preparation of (quinolin-4-yl) methane amine
02/04/2015CN104326977A 一种6,7-二乙基-4-羟基喹啉的制备方法 One kind of method for preparing 6,7-diethyl-4-hydroxy quinoline
02/04/2015CN104326976A 一种孟鲁司特钠中间体的制备方法 A method for preparing montelukast sodium intermediates
02/04/2015CN102731395B 抗肿瘤药物来那替尼的中间体及其制备与应用 Antineoplastic neratinib intermediates and their preparation and application
02/04/2015CN102558049B 一类双香豆素类化合物及其制备方法和用途 A class of two coumarins their preparation and use
02/04/2015CN102015606B IRE-1α抑制剂 IRE-1α inhibitor
02/03/2015US8946446 Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-γ (ROR-γ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
02/03/2015US8946442 Foamed ionic compounds
02/03/2015US8946439 Amide compounds, compositions and uses thereof
02/03/2015US8946431 2-(substituted ethynyl)quinoline derivatives as mGLUr5 antagonists
02/03/2015US8946430 Quinolinone carboxamide inhibitors of endothelial lipase
02/03/2015US8946261 Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of Alzheimer's disease
02/03/2015US8946255 Substituted morphinans and the use thereof
02/03/2015US8946197 Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
02/03/2015US8946195 Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
02/03/2015US8945725 Organic electroluminescence device
02/03/2015US8945723 Organometallic complexes and organic electroluminescence device using the same
01/2015
01/29/2015WO2015013431A1 T-box riboswitch-binding anti-bacterial compounds
01/29/2015WO2015012298A1 Quinoline derivative
01/29/2015WO2015011087A1 Substituted oxopyridine derivatives and use thereof as factor xia/plasma
01/29/2015WO2015011081A2 Intercalating amino acids
01/29/2015US20150031723 Quinoline Compounds Which Are Anti-Angiogenic Integrin Alpha5 Beta1 Inhibitors for Use in the Treatment of Fibrosis or Fibrosis-Related Diseases
01/29/2015US20150031714 Methods and compositions for prevention of allergic reaction
01/29/2015US20150031663 Phthalanilate compounds and methods of use
01/28/2015EP2829535A1 Intercalating amino acids
01/28/2015EP2828242A1 NOVEL POLYMORPHIC CRYSTAL FORMS OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-(R)-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE, HEMINAPADISYLATE AS AGONIST OF THE ß2 ADRENERGIC RECEPTOR.
01/28/2015CN104311486A 2-羰基-1,2-二氢喹啉免疫功能调节剂 2-oxo-1,2-dihydroquinoline immune function modulator
1 2 3 4 5 6 7 8 9 10 11 ... 277